Log in to save to my catalogue

POS0716 DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS

POS0716 DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3066095028

POS0716 DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS

About this item

Full title

POS0716 DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS

Publisher

Kidlington: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.719-719

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Limited

More information

Scope and Contents

Contents

Background:In recent decades, immune checkpoint inhibitors (ICIs) have gained popularity in the treatment of various cancers, but immune-related adverse events (irAEs) can impact the effectiveness of ICIs in killing tumors. Arthritis, occurring in approximately 10% of ICI-treated cancer patients, not only diminishes the quality of life but may also...

Alternative Titles

Full title

POS0716 DEVELOPMENT OF PRECLINICAL MODELS FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ARTHRITIS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3066095028

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3066095028

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2024-eular.706

How to access this item